A phase 3 trial explores whether adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improves overall survival in patients with gastric cancer and peritoneal metastasis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/can-intraperitoneal-paclitaxel-improve-survival-gastric-2026a1000gmg?src=rss
Author :
Publish date : 2026-05-22 06:59:00
Copyright for syndicated content belongs to the linked Source.
